The topline data showed that ATH434 produced clinically and statistically significant improvement on the modified UMSARS Part I, a functional rating scale that assesses disability on activities of ...

Alterity Therapeutics (ATHE) announced topline results from the ATH434-201 randomized, double-blind, placebo-controlled Phase 2 clinical trial ...

Alterity Therapeutics (ATHE) stock jumps as its lead asset, ATH434, shows promise in slowing clinical progression in multiple ...

Alterity Therapeutics (NASDAQ: ATHE) shares moved up at warp-speed Thursday, on announcing positive topline results from the ATH434-201 randomized, double-blind, placebo-controlled Phase 2 clinical ...

The following is a summary of “Spinal cord gray matter atrophy is associated with disability in spinal muscular atrophy,” published in the January 2025 issue of Neurology by Kesenheimer et al. With ...

Physician empathy has long been recommended — but not required — in the doctor-patient relationship.However, for a growing ...

U.S. companies that scale back workplace diversity efforts to avoid scrutiny from the Trump administration may be exposing ...

“When companies are sued by women or people of color and they’re held liable for discrimination … the Trump administration can’t save them and nothing in this executive order can save them,” said ...

US companies that scale back workplace diversity efforts to avoid scrutiny from the Trump administration may be exposing themselves to more discrimination lawsuits by ...

The Care Quality Commission (CQC), has rated Gloucestershire County Council as requires improvement, in how well they are meeting their responsibilities to ensure people have access to adult social ...